Companies founded on innovation and strong science

Arxx Therapeutics

Arxx Therapeutics merged with Oxitope Pharma in 2024 to form Calluna Pharma. P53 took part in the subsequent Series A round which was led by Forbion.

Sector: Biotechnology

Country: Norway/Denmark

Year of first investment: 2019

Status: Exited

Website: arxxtx.com